Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Paul Shread who wrote (6015)	10/14/1998 2:45:00 PM
From: HiSpeed	Read Replies (1) \| Respond to of 9523

Re MRK. Your points are well taken and the drugs coming off-patent maybe priced into the stock. I would need more details on what's in their pipeline before I went long MRK, though. As for PFE, I think all the viagra hype was priced in months ago when the stock first hit 120+. PFE is well known for being well run, continuously having promising drugs in the pipeline, and also having an excellent sales force. Given those, I like it better than MRK. But, admittedly, I would be hard pressed to give future prices 5 years out on either. I do believe the PFEs FAs are superior. The earnings miss did catch me off guard. And, honestly, today's action isn't what I expected either.